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GTP catabolism induced by sodium azide or deoxyglucose was studied in purine nucleoside phosphorylase 
(PNP) deficient human B lymphoblastoid cells. In PNP deficient cells, as in control cells, guanylate was 
both dephosphorylated and deaminated but dephosphorylation was the major pathway. Only nucleosides 
were excreted during GTP catabolism by PNP deficient cells and the main product was guanosine. The 
level of nucleoside excretion was largely affected by intracellular orthophosphate (Pi) level. In contrast, 
normal cells excreted nucleosides only at low Pi level while at high Pi levels, purine bases (guanine and 
hypoxanthine) were exclusively excreted. PNP deficiency had no effect on the extent of GMP de~ination. 
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1. INTRODUCTION 
Deficiency of the purine nucleoside phosphory- 
lase (PNP) in humans is associated with T-lympho- 
cyte abnormalities and results in large urine excre- 
tion of purine nucleosides [l], the substrates of 
PNP. Both inosine and guanosine are found in the 
urine of PNP deficient patients while guanosine is 
the direct catabolic product of GTP catabolism, 
inosine may be produced either by ATP catabolism 
or as a catabolic product for GTP degradation. 
Guanylate formed during GTP catabolism can be 
dephosphorylated to guanosine by 5 ’ -nucleotidase 
(EC 3.1.3.5) and nonspecific phosphatases (EC 
3.1.3.1 and 3.1.3.2), or GMP can bedeaminated to 
IMP by GMP reductase (EC 1.6.6.8) [2]. 
of GMP occurred at low rates in erythrocytes in- 
cubated with or without glucose [3]. On the other 
hand, in Ehrlich ascites tumor cells incubated with 
deoxyglucose GMP was only dephosphorylated 171 
and less than 1% of GMP was deaminated to IMP. 
Our aim was to evaluate the catabolism of GTP 
and the importance of its alternative pathways, i.e. 
GMP dephosphorylation vs GMP deamination, in 
human B lymphoblastoid cells with PNP deficien- 
cy, where phosphorylisis of purine nucleosides is 
impaired. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
It was believed that in mammalian cells GMP is 
catabolized only via dephospho~lation [2] and 
reductive deamination of GMP is qu~titatively 
important only in bacteria [3]. However, later 
studies demonstrated the presence of guanylate 
reductase activities in rabbit and human 
erythrocytes [4,5] in calf thymus [6]. Deamination 
[8-3H]Guanosine was purchased from ICN (Ir- 
vine, CA). Nonradioactive purine bases, nucleosi- 
des, nucleotides and 2-deoxy-D-glucose were pur- 
chased from Sigma (St. Louis, MO). Sodium azide 
was from Fisher (NJ). 
Freon TF was purchased from DuPont 
(Maitland, Ont.), and Alamine 336 from Hankel 
(Kankakee, IL). 
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RPMI-1640 medium was obtained from Grand 
Island Biologicals (Burlington, Ont.), PEI-cellu- 
lose TLC sheets from Fisher (Don Mills, Ont.), 
and cellulose-TLC from Eastman Kodak 
(Rochester, NY). 
2.2. Cd& 
2.2.1. Mononuclear cell preparation, cell culture 
conditions 
Mononuclear cells from peripheral blood were 
separated on Ficoll-Hypaque (specific gravity 
1.077) as in [8]. Complete culture media consisted 
of RPMI-1640 with penicillin (100 units/ml}, 
streptomycin (100 pg/ml), 2 mM glutamine and 
15% heat-inactivated fetal bovine serum. 
2.2.2. Virus stock, infection procedure 
Epstein-Barr Virus (EBV) was obtained from 
EBV transformed marmoset lymphocytes, strain 
B95-8, and prepared as in [9]. EBV infection was 
performed by incubating PNP deficient patient’s 
mononuclear cell preparation with EBV for 2 h at 
37°C. The mononuclear cells were washed 3 times, 
then placed in long-term culture. Cultures were fed 
periodically as necessitated by expansion of the 
transformed cell population. 
As the control cells spontaneously transformed 
EBNA negative IgM/A producing human B-cell 
line was used. 
2.2.3. Incubation 
Cells (2x 10’) were incubated with 2 &i 
[8-3H]guanine (20 Ci/mmol) to synthesize radioac- 
tive GTP. After 20-60 min incubation unutilized 
precursor was washed out and the cells were 
resuspended in 0.15 pM NaCl and 2 x 1 O6 cells were 
used for 0, 5, 10, 20; 30 min incubation with 5.5 
mM deoxyglucose or 1 mM sodium azide to induce 
GTP catabolism. After incubation cells were col- 
lected by centrifugation and the radioactivity of 
purine nucleosides and bases was determined in the 
medium. The cell pellet was extracted with 50~1 of 
0.4 M perchloric acid and extracts were neutralized 
with Alamine 336Freon [lo], and then used for 
ribonucleotide analysis. 
2.3. Separation of puke nucleotides, nucleosides 
and bases 
Nucleotides were separated by thin-layer 
chromatography on PEI-cellulose in increased 
concentrations of formate buffer [ 111. Separation 
of nucleosides and bases was carried out on Kodak 
cellulose thin-layer chromatograms in 5% 
NazHP04-water solvent. Spots were localized 
under ultraviolet lamp and their radioactivity was 
counted in a Beckman LS 2800 counter. In- 
tracellular concentrations of guanine nucleotides 
measured by high-pressure liquid chromatography 
were taken into account in the calculations of 
results. 
3. RESULTS AND DISCUSSION 
These studies were conducted using PNP defi- 
cient (less than 0.3% of the activity in cell extract) 
human B lymphoblastoid cells. 
To synthesize radioactive GTP, cells were in- 
cubated with radioactive guanine. After 1 h in- 
cubation, amounts of radioactive GTP formed 
were similar (3-4 pmol/lO cells) in both PNP defi- 
cient and normal cells indicating that the extents of 
GMP formation via salvage pathways from 
guanine and further phosphorylations were also 
similar. To induce GTP catabolism cells were in- 
cubated with sodium azide or deoxyglucose. These 
inductors work by different mechanisms and they 
increase or decrease intracellular Pi level, respec- 
tively [ 121. In PNP deficient as well as normal 
cells, sodium azide and deoxyglucose caused rapid 
GTP breakdown. 
In both PNP deficient and normal cells, sodium 
azide induced large accumulation of GMP and 
relatively small amounts of IMP were formed. The 
accumulation of large amounts of nucleoside 
monophosphates are a result of inhibition of 
dephosphorylation by high intracellular Pi level 
(fig,lA,2A). At low Pi level (cells treated with de- 
oxyglucose), no GMP accumulation was observed 
because of increased ‘dephosphorylation of GMP 
(fig. lC,2C). 
Comparison of the excretion of purine bases and 
nucleosides by PNP deficient and normal cells 
reveals marked differences. 
In normal cells, induction of GTP catabolism by 
sodium azide results in the production of large 
amounts of guanine and some hypoxanthine 
(fig.2B) but no nucleosides were found since at 
high Pi levels nucleoside phosphorolysis is com- 
pleted. Induction of GTP degradation in normal 
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Fig, 1. GTP catabolism in human PNP deficient B 
lymphoblastoid cells. Cells (2 x 10’) were incubated with 
2 ,&I [8-3H]guanine. After 60 min incubation unused 
guanine was removed and 2 x IO6 cells in 0.15 PM NaCf 
were incubated with 1 mM sodium azide (A&Q or 5.5 
mM deoxyglucose (CD). Nucleotides GTP (o), GDP 
(0), GMP (A) and IMP (A) were analyzed in cell 
extracts, and nucleosides and bases guanosine (a), 
cells by deoxyglucose results in excretion of large 
amounts of guanosine and some of inosine, in ad- 
dition to guanine and hypoxanthine (fig.ZI?). This 
indicates that at low Pi level nucleoside 
phosphorolysis by PNP is impaired and guanosine 
cleavage is not completed. In contrast, in PNP 
deficient cells guanosine formed in the presence of 
either sodium azide or deoxyglucose was not 
metabolized and therefore excreted to the medium 
in large amounts (fig.lB,D). In addition to 
guanosine, inosine was also excreted by PNP defi- 
cient cells. Total purine excretion by both P’NP 
deficient and normal cells was significantly in- 
creased at low Pi Ievefs as a result of enhanced 
GMP dephosphoryiation. Similar results were ob- 
tained for PNP deficient mouse T lymphoblastoid 
cells (not shown). 
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Fig. 2. GTP catabolism in human B lymphoblastoid 
control cells. Nudeotides GTP (*)? GDP (0), GMP (A) 
and IMP (A) were analyzed in cell extracts, and 
nucleosides and bases guanosine (0). guanine (A), 
inosine (0) and hypoxanthine (A) in incubation 
The accumulation of IMP and the secretion of 
inosine and h~ox~thine as degradation products 
of GTP catabolism indicate that reductive 
deamination of GMP is active in both PNP defi- 
cient and in normal lymphoblastoid cells, and 
represents l&B-15% of the total GTP catabolised, 
In contrast, AMP deamination represents the ma- 
jor pathway of ATP catabolism whereas AMP 
dephosphorylation participates only to small 
degrees [13,14]. 
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